论文部分内容阅读
目的:探讨β-受体阻滞剂在高血压治疗中的临床价值。方法:以我院收治的74例高血压患者为研究对象,根据其临床资料进行回顾性分析。患者均采用β-受体阻滞剂治疗,在治疗过程中观察不良反应的发生情况,并对其治疗效果进行评定。结果:治疗后患者舒张压、收缩压均较治疗前显著降低,差异显著(p<0.05);58例患者血压水平控制在139/90mm Hg以下,血压控制有效率为78.4%;25例患者出现不良反应,不良反应发生率为33.8%。结论:β-受体阻滞剂治疗高血压的效果显著,在降压方面具有较高的应用价值;但会使患者产生一系列的不良反应,因此,在临床使用过程中应严格掌握禁忌证和适应证,提高临床用药的合理性。
Objective: To investigate the clinical value of β-blockers in the treatment of hypertension. Methods: Totally 74 hypertensive patients admitted to our hospital were studied retrospectively according to their clinical data. Patients were treated with β-blockers, the incidence of adverse reactions observed in the course of treatment, and to assess the therapeutic effect. Results: After treatment, the diastolic blood pressure and systolic blood pressure of patients were significantly lower than those before treatment (p <0.05). The blood pressure of 58 patients was controlled below 139/90 mm Hg and the effective rate of blood pressure control was 78.4%. Twenty-five patients Adverse reactions, the incidence of adverse reactions was 33.8%. Conclusion: The effect of β-blocker in the treatment of hypertension is significant, and it has high value in lowering blood pressure; however, it will cause a series of adverse reactions in patients. Therefore, contraindications should be strictly controlled during clinical use And indications, to improve the rationality of clinical medication.